What is a common side effect of platinum-based chemotherapy agents?

What is a common side effect of platinum-based chemotherapy agents?

• A. Fatigue
• B. Nausea
• C. Nephrotoxicity
• D. Loss of appetite

Answer: (C)

Platinum-based chemotherapy agents, such as cisplatin, carboplatin, and oxaliplatin, are well-known for their effectiveness in treating various solid tumors. One of the notable side effects associated with these agents is nephrotoxicity, which refers to the potential for kidney damage. The kidneys are responsible for filtering the blood and excreting waste products, and platinum compounds can induce acute kidney injury through several mechanisms, including direct tubular toxicity and the formation of reactive oxygen species that can harm renal cells. Nephrotoxicity can lead to impaired kidney function, electrolyte imbalances, and, in severe cases, chronic kidney disease. In a clinical setting, monitoring renal function through blood tests and adjusting the dosage of platinum-based agents accordingly is crucial to mitigate this risk. Hydration and the use of nephroprotective agents may also be employed to enhance renal protection during treatment. While fatigue, nausea, and loss of appetite are also common side effects of chemotherapy in general, nephrotoxicity specifically highlights a critical concern associated with platinum-based drugs, making it the correct answer in this context.

Platinum-based chemotherapy agents, such as cisplatin, carboplatin, and oxaliplatin, are well-known for their effectiveness in treating various solid tumors. One of the notable side effects associated with these agents is nephrotoxicity, which refers to the potential for kidney damage.

The kidneys are responsible for filtering the blood and excreting waste products, and platinum compounds can induce acute kidney injury through several mechanisms, including direct tubular toxicity and the formation of reactive oxygen species that can harm renal cells. Nephrotoxicity can lead to impaired kidney function, electrolyte imbalances, and, in severe cases, chronic kidney disease.

In a clinical setting, monitoring renal function through blood tests and adjusting the dosage of platinum-based agents accordingly is crucial to mitigate this risk. Hydration and the use of nephroprotective agents may also be employed to enhance renal protection during treatment.

While fatigue, nausea, and loss of appetite are also common side effects of chemotherapy in general, nephrotoxicity specifically highlights a critical concern associated with platinum-based drugs, making it the correct answer in this context.